3Shigeta O,Kojima H,Hiramatsu Y,et al.Low-dose protamine based on heparin-protamine titration method reduces platelet dysfuction after cardiopulmonary bypass.J Thorac Cardiovasc Surg,1999,118(2):354-360.
4Weiler JM,Gellhaus MA,Carter JG,et al.A prospective study of the risk of an immediate adverse reaction to protamine sulfate during cardiopulmonary bypass surgery.J Allergy Clin Immunol,1990,85(4):713-719.
5Oe M,Asou T,Morita S,et al.Protamine-induced.hypotension in heart operations:application of the concept of ventricular-arterial coupling.J Thorac Cardiovasc Surg,1996,112(2):462-471.
6Seifert HA,Jobes DR,Ten Have T,et al.Adverse events after protamine administration following cardiopulmonary bypass in infants and children.Anesth Analg,2003,97(2):383-389.
7Elison N,Horrow JC.Coagulation and coagulopathies.In:Youngberg JA,ed.Cardiac,vascular,and thoracic anesthesia.New York:Churchill Livingstone,2000.789-790.
8Brooks JC.Noncardiogenic pulmonary edema immediately following rapid protamine administration.Ann Pharmacother,1999,33(9):927-930.
9Kimmel SE, Sekeres MA, Berlin JA. Risk factor for clinically important adverse events after protamine administration following cardiopulmonary bypass[J]. Am J Cardiol,1998,32(7) :1 916 -1 920.
10Pevmi D, Gurevich J, Frolkis I. Protamine induces vasorelaxation of human internal thoracic artery by endothelial NO-synthase pathway [J]. Ann Thorac Surg,2000,70(6) :2 050 -2 057.
